Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
alvocidib (DSP-2033)
i
Other names:
DSP-2033, L868275, HL-275, HMR 1275, IND 46211, L 868275, MDL-107826A, NSC 649890, flHMR-1275
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(8)
News
Trials
Company:
Sumitomo Pharma
Drug class:
CDK4 inhibitor, CDK6 inhibitor, CDK9 inhibitor
Related drugs:
‹
palbociclib (222)
abemaciclib (80)
ribociclib (62)
dalpiciclib (11)
trilaciclib (3)
PRT3645 (3)
RGT-419B (2)
XZP 3287 (2)
TQB3616 (2)
HX301 (2)
CS3002 (1)
FCN-437 (1)
GLR2007 (1)
PF-07220060 (1)
PF-06873600 (1)
G1T38 (1)
BPI-16350 (1)
AM-5992 (0)
BPI-1178 (0)
FLX925 (0)
FN-1501 (0)
HS-10342 (0)
PF-07224826 (0)
SPH4336 (0)
SRX3177 (0)
SYH2043 (0)
TY-0540 (0)
TY-302 (0)
Undisclosed CDK4/6 inhibitor (0)
XH-30002 (0)
NUV-422 (0)
KB-0742 (8)
CYC065 (6)
VIP152 (5)
ME-522 (3)
TG02 (2)
BTX-A51 (1)
CDDD11-8 (1)
PRT2527 (1)
SLS009 (1)
AZD4573 (1)
A-1592668 (0)
TP-1287 (0)
BAY 1143572 (0)
CYC202 (0)
palbociclib (222)
abemaciclib (80)
ribociclib (62)
dalpiciclib (11)
trilaciclib (3)
PRT3645 (3)
RGT-419B (2)
XZP 3287 (2)
TQB3616 (2)
HX301 (2)
CS3002 (1)
FCN-437 (1)
GLR2007 (1)
PF-07220060 (1)
PF-06873600 (1)
G1T38 (1)
BPI-16350 (1)
AM-5992 (0)
BPI-1178 (0)
FLX925 (0)
FN-1501 (0)
HS-10342 (0)
PF-07224826 (0)
SPH4336 (0)
SRX3177 (0)
SYH2043 (0)
TY-0540 (0)
TY-302 (0)
Undisclosed CDK4/6 inhibitor (0)
XH-30002 (0)
NUV-422 (0)
KB-0742 (8)
CYC065 (6)
VIP152 (5)
ME-522 (3)
TG02 (2)
BTX-A51 (1)
CDDD11-8 (1)
PRT2527 (1)
SLS009 (1)
AZD4573 (1)
A-1592668 (0)
TP-1287 (0)
BAY 1143572 (0)
CYC202 (0)
›
Associations
(8)
News
Trials
VERI cancer hierarchy
Reset Filters
CDK1 overexpression
Adrenal Cortex Carcinoma
CDK1 overexpression
Adrenal Cortex Carcinoma
DSP-2033
Sensitive: D – Preclinical
DSP-2033
Sensitive
:
D
DSP-2033
Sensitive: D – Preclinical
DSP-2033
Sensitive
:
D
CDK2 overexpression
Adrenal Cortex Carcinoma
CDK2 overexpression
Adrenal Cortex Carcinoma
DSP-2033
Sensitive: D – Preclinical
DSP-2033
Sensitive
:
D
DSP-2033
Sensitive: D – Preclinical
DSP-2033
Sensitive
:
D
MCL1 expression
Acute Myelogenous Leukemia
MCL1 expression
Acute Myelogenous Leukemia
DSP-2033
Sensitive: D – Preclinical
DSP-2033
Sensitive
:
D
DSP-2033
Sensitive: D – Preclinical
DSP-2033
Sensitive
:
D
MCL1 expression
Myelodysplastic Syndrome
MCL1 expression
Myelodysplastic Syndrome
DSP-2033
Sensitive: D – Preclinical
DSP-2033
Sensitive
:
D
DSP-2033
Sensitive: D – Preclinical
DSP-2033
Sensitive
:
D
ASXL1 mutation
Myelodysplastic Syndrome
ASXL1 mutation
Myelodysplastic Syndrome
DSP-2033
Sensitive: D – Preclinical
DSP-2033
Sensitive
:
D
DSP-2033
Sensitive: D – Preclinical
DSP-2033
Sensitive
:
D
ZRSR2 mutation
Myelodysplastic Syndrome
ZRSR2 mutation
Myelodysplastic Syndrome
DSP-2033
Sensitive: D – Preclinical
DSP-2033
Sensitive
:
D
DSP-2033
Sensitive: D – Preclinical
DSP-2033
Sensitive
:
D
ASXL1 Y588X
Myelodysplastic Syndrome
ASXL1 Y588X
Myelodysplastic Syndrome
DSP-2033
Sensitive: D – Preclinical
DSP-2033
Sensitive
:
D
DSP-2033
Sensitive: D – Preclinical
DSP-2033
Sensitive
:
D
MCL1 amplification
Ewing Sarcoma
MCL1 amplification
Ewing Sarcoma
DSP-2033
Sensitive: D – Preclinical
DSP-2033
Sensitive
:
D
DSP-2033
Sensitive: D – Preclinical
DSP-2033
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login